TAT-Gap19 and carbenoxolone alleviate liver fibrosis in mice (2018)
- Authors:
- Yanguas, Sara Crespo
- Silva, Tereza Cristina da - Universidade de São Paulo (USP)
- Pereira, Isabel Veloso Alves - Universidade de São Paulo (USP)
- Willebrords, Joost
- Maes, Michaël
- Nogueira, Marina Sayuri - Universidade de São Paulo (USP)
- Castro, Inar Alves de
- Leclercq, Isabelle
- Romualdo, Guilherme Ribeiro - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
- Barbisan, Luis Fernando - Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP)
- Leybaert, Luc
- Cogliati, Bruno
- Vinken, Mathieu
- USP affiliated authors: COGLIATI, BRUNO - FMVZ ; ERGER, INAR CASTRO - FCF
- Unidades: FMVZ; FCF
- DOI: 10.3390/ijms19030817
- Subjects: HEPATOPATIAS; CONEXINAS; FIBROSE CÍSTICA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: International Journal of Molecular Sciences
- ISSN: 1661-6596
- Volume/Número/Paginação/Ano: v. 19, n. 3, art. 817, p. 1-17, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
YANGUAS, Sara Crespo et al. TAT-Gap19 and carbenoxolone alleviate liver fibrosis in mice. International Journal of Molecular Sciences, v. 19, n. 3, p. 1-17, 2018Tradução . . Disponível em: https://doi.org/10.3390/ijms19030817. Acesso em: 19 abr. 2024. -
APA
Yanguas, S. C., Silva, T. C. da, Pereira, I. V. A., Willebrords, J., Maes, M., Nogueira, M. S., et al. (2018). TAT-Gap19 and carbenoxolone alleviate liver fibrosis in mice. International Journal of Molecular Sciences, 19( 3), 1-17. doi:10.3390/ijms19030817 -
NLM
Yanguas SC, Silva TC da, Pereira IVA, Willebrords J, Maes M, Nogueira MS, Castro IA de, Leclercq I, Romualdo GR, Barbisan LF, Leybaert L, Cogliati B, Vinken M. TAT-Gap19 and carbenoxolone alleviate liver fibrosis in mice [Internet]. International Journal of Molecular Sciences. 2018 ; 19( 3): 1-17.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3390/ijms19030817 -
Vancouver
Yanguas SC, Silva TC da, Pereira IVA, Willebrords J, Maes M, Nogueira MS, Castro IA de, Leclercq I, Romualdo GR, Barbisan LF, Leybaert L, Cogliati B, Vinken M. TAT-Gap19 and carbenoxolone alleviate liver fibrosis in mice [Internet]. International Journal of Molecular Sciences. 2018 ; 19( 3): 1-17.[citado 2024 abr. 19 ] Available from: https://doi.org/10.3390/ijms19030817 - Effect of oxidized oil consumption on biomarkers of atherosclerosis in LDLr knockout mice
- Genetic ablation of pannexin1 counteracts liver fibrosis in a chemical, but not in a surgical mouse model
- Effect of long-term ingestion of weakly oxidised flaxseed oil on biomarkers of oxidative stress in LDL-receptor knockout mice
- Protective effect of genetic deletion of pannexin1 in experimental mouse models of acute and chronic liver disease
- Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice
- Comparison between red wine and isolated trans-resveratrol on the prevention and regression of atherosclerosis in LDLr (−/−) mice
- Connexin32 deficiency exacerbates carbon tetrachloride-induced hepatocellular injury and liver fibrosis in mice
- Burdock (Arctium lappa L.) root attenuates preneoplastic lesion development in a diet and thioacetamide-induced model of steatohepatitis-associated hepatocarcinogenesis
- Connexin32 deficiency is associated with liver injury, inflammation and oxidative stress in experimental non-alcoholic steatohepatitis
- Effect of resveratrol or red wine on oxidative stress biomarkers associated with atherosclerosis in LDL-r-KO mice
Informações sobre o DOI: 10.3390/ijms19030817 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
